Citations

Clear

1825 citation(s) found for "Yu, Emily".

Feasibility and Safety of Outpatient Hypomethylating Agent (HMA) + Venetoclax (Ven) Initiation +/- Ramp-up for Patients (pts) with Newly-Diagnosed Acute Myeloid Leukemia (AML)
Shallis, Rory M. , Winer, Eric S. , Doukas, Peter H., Geramita, Emily , Agarwal, Sonal , Merl, Man Yee, Im, Annie , Litzow, Mark R. , Weiss, Julian J , Badar, Talha , Swaroop, Alok , Doukas, Peter, Le, Henry, Abaza, Yasmin , Podoltsev, Nikolai

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8921-8922

10.1182/blood-2022-165446 Get It

A Phase 1b Dose Escalation and Expansion Study of SNDX-5613, Azacitidine (AZA) and Venetoclax (VEN) in Newly Diagnosed, Patients ≥ 60 Years with Untreated NPM1-Mutated/ FLT3-Wild Type AML or KMT2A-Rearranged Acute Myeloid Leukemia (AML
Johnson, Mary Ann , Huang, Ying , Swords, Ronan , Stein, Eytan M. , Foran, James M. , Baer, Maria R. , Kovacsovics, Tibor , Olin, Rebecca L. , Blum, William , Schiller, Gary J. , Redner, Robert L. , Al‐Mansour, Zeina , Curran, Emily , Heerema, Nyla A. , Martycz, Molly , Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O. , Stefanos, Mona , Druggan, Franchesca , Burd, Amy , Borate, Uma , Byrd, John C. , Byrd, John C , Zeidner, Joshua F. , Foster, Matthew C , Johnson, Mary, Stock, Wendy , Madanat, Yazan F. , Lin, Tara L. , Chen, Timothy Frank , Levine, Ross L. , Druker, Brian J , Mims, Alice S

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9070-9073

10.1182/blood-2022-166715 Get It

Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
Geramita, Emily , Bastacky, Melissa, Cohen, Jessica B, Shallis, Rory M. , Litzow, Mark R. , Im, Annie , Wang, Hong , Bastacky, Melissa L. , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6187-6188

10.1182/blood-2022-170647 Get It

A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
Kairalla, John A. , Hibbitts, Emily , Carroll, Andrew J. , Heerema, Nyla A. , Kubaney, Holly R. , August, Amanda, Wechsler, Daniel S. , Miles, Rodney R., Kihei, Cynthia D., Gore, Lia , Raetz, Elizabeth A. , Brown, Patrick A. , Guest, Erin M. , Devidas, Meenakshi , Pauly, Melinda , Reid, Joel M. , Hunger, Stephen P. , Loh, Mignon L.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3256-3257

10.1182/blood-2022-167765 Get It

Efficacy of CD19 Directed Therapies in Large B-Cell Lymphoma (LBCL) Relapsing after Chimeric Antigen Receptor (CAR) T-Cell Therapy
Khurana, Arushi , Chavez, Julio, Craver, Emily C. , Aditi, Saha, Annunzio, Kaitlin , Isufi, Iris, Fijalka, Andrew, Sandoval‐Sus, Jose , Ivanov, Stanislav , Lin, Yi , Kharfan‐Dabaja, Mohamed A. , Saha, Aditi , Saha, Aditi , Iqbal, Madiha , Rosenthal, Allison , Li, Zhuo , Aditi, Saha, Epperla, Narendranath , Awan, Farrukh T. , Dholaria, Bhagirathbhai , Bhaskar, Shakthi , Maakaron, Joseph E. , Sumransub, Nuttavut

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10396-10398

10.1182/blood-2022-169689 Get It

Pembrolizumab in Combination with Epigenetic Therapy Is Safe and Active in Heavily Treated Patients with Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL): Preliminary Results from the Embolden Trial
Lister, John , Jain, Salvia , Battaglia, Tammy, Ayers, Emily C. , Portell, Craig A. , Williams, Michael E. , Pal, Ipsita , O’Connor, Owen A. , Manavalan, John S., Marchi, Enrica , Portell, Craig A , Roberts, Nathan, Bennani, N. Nora , Batchala, Prem Pradeep

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9425-9426

10.1182/blood-2022-170181 Get It

Prevalence of Vitamin C Deficiency and Bleeding at a Tertiary Care Center: Mayo Clinic Florida (MCF) Experience
Kimbrough, ErinMarie O. , Mooradian, Ariana, Peng, Zhongwei , Butts, Emily, Gococo-Benore, Denise A. , Wysokinska, Ewa , Johns, Gretchen S., Foran, James M. , Heckman, Michael G. , Rahman, Zaid Abdel

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1420-1421

10.1182/blood-2022-170199 Get It

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review
Tran, Diana , Rosta, Emily, Laidlaw, Alyshia , Rai, Manvir, Duran, Joana , Ammann, Eric M. , Fonseca, Rafaël

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5212-5213

10.1182/blood-2022-165569 Get It

Entospletinib (ENTO) in Combination with Cytarabine (Ara-C) and Daunorubicin (DNR) in Newly Diagnosed (ND) Adult Patients with NPM1-Mutated and FLT3-ITD Wild-Type Acute Myeloid Leukemia (AML) Is Associated with Good Response and Survival: A P
Borate, Uma , Li, Rui , Huang, Ying , Swords, Ronan , Stein, Eytan M. , Foran, James M. , Baer, Maria R. , Odenike, Olatoyosi , Patel, Prapti A. , Collins, Robert H. , Kovacsovics, Tibor , Deininger, Michael W. , Olin, Rebecca L. , Arellano, Martha , Blum, William , Schiller, Gary J. , Boyiadzis, Michael , Redner, Robert L. , Al‐Mansour, Zeina , Curran, Emily , Heerema, Nyla A. , Gana, Theophilus J. , Martycz, Molly , Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O. , Stefanos, Mona , Druggan, Franchesca , Burd, Amy , Byrd, John C. , Byrd, John C , Traer, Elie , Duong, Vu H. , Stock, Wendy , Madanat, Yazan F. , Smith, Catherine C. , Lin, Tara L. , Foster, Matthew C , Chen, Timothy Frank , Levine, Ross L. , Druker, Brian J , Mims, Alice S

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6200-6203

10.1182/blood-2022-167316 Get It